Compare BIO & UGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | UGP |
|---|---|---|
| Founded | 1952 | 1937 |
| Country | United States | Brazil |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil/Gas Transmission |
| Sector | Industrials | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.7B |
| IPO Year | N/A | 2001 |
| Metric | BIO | UGP |
|---|---|---|
| Price | $254.19 | $5.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $339.75 | $5.37 |
| AVG Volume (30 Days) | 241.5K | ★ 2.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $9.93 |
| Revenue Next Year | $3.20 | $3.25 |
| P/E Ratio | ★ $9.72 | $9.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $2.80 |
| 52 Week High | $343.12 | $6.14 |
| Indicator | BIO | UGP |
|---|---|---|
| Relative Strength Index (RSI) | 33.87 | 60.40 |
| Support Level | $246.01 | $5.65 |
| Resistance Level | $289.61 | $6.14 |
| Average True Range (ATR) | 10.43 | 0.13 |
| MACD | -3.76 | -0.02 |
| Stochastic Oscillator | 17.46 | 63.92 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Ultrapar Participacoes SA engages in the investment of its own capital in services, commercial, and industrial activities, through the subscription or acquisition of shares of other companies. The company's business segments include: i) Ultragaz distributes LPG in the segments: bulk, comprising condominiums, trade, services, industries, and agribusiness; and bottled, mainly comprising residential consumers. ii) Ipiranga, the majority revenue generating segment, engages in the distribution and sale of oil-related products to service stations that operate under the Ipiranga brand throughout Brazil. iii) Ultracargo operates in specialized liquid bulk storage solutions in the main logistics centers. iv) Hidrovias: operates in logistics solutions and waterway and multimodal infrastructure.